TUBERCULOSIS
TUBERCULOSIS
TUBERCULOSIS
CONTENT
• DEFINITION
• SYMPTOMS
• CAUSES
• RISK FACTORS
• DIAGNOSIS EVALUATION
• TREATMENT
• RISKS AND BENEFITS OF TREATMENT
• PREVENTION
DEFINITION
• Tuberculosis (TB) is a potentially
serious infectious disease that
mainly affects the lungs. (Mayo
Clinic, 2020)
• Neo-latin word
a) Tubercle- Round
Nodule/Swelling
b) Osis- Condition
Causes
• Tuberculosis (TB) is caused by a
bacterium called Mycobacterium
tuberculosis.
CLASSIFICATICATION
who
Common disease
• Tuberculosis
• Hansen’s disease (also known as
leprosy)
Syupmtos
• weakness or fatigue
• weight loss
• no appetite
• chills
• fever
• sweating at night
cdc
Virulence
• TB bacteria can attack any part of the body
such as the kidney, spine, and brain.cdc
• Globally, an estimated 10.0 million (range,
8.9–11.0 million)people fell ill with TB in
2019,WHO
• A total of 1.4 million people died from TB in
2019
• TB occurs in every part of the world. In 2019,
the largest number of new TB cases occurred
in the WHO South-East Asian region, with
44% of new cases, followed by the WHO
African region, with 25% of new cases and
the WHO Western Pacific with 18%.
How TB Spreads
• TB bacteria are spread through the air
from one person to another.airbonre
• When a person breathes in TB bacteria,
the bacteria can settle in the lungs and
begin to grow. From there, they can move
through the blood to other parts of the
body, such as the kidney, spine, and brain.
• TB disease in the lungs or throat can be
infectious. This means that the bacteria
can be spread to other people. TB in other
parts of the body, such as the kidney or
spine, is usually not infectious.
• CDC
PREVENTION
• The vaccine called Bacillus Calmette-Guerin (BCG).
• Managing your environment
• As TB is an airborne infection, TB bacteria are released into
the air when someone with infectious TB coughs or sneezes.
The risk of infection can be reduced by using a few simple
precautions:
• Isoniazid
• Rifampin (Rifadin, Rimactane)
• Ethambutol (Myambutol)
• Pyrazinamide
• If you have drug-resistant TB, a combination of
antibiotics called fluoroquinolones and injectable
medications, such as amikacin or capreomycin
(Capastat), are generally used for 20 to 30
months.